These findings highlight H2S as a potential therapeutic strategy to combat cellular aging and enhance stem cell‐based treatments for oral diseases.[92] CCL11 antibody enhances pulp regeneration in aged mice by reducing blood CCL11 levels and shifting macrophage polarization toward an M2 phenotype, decreasing the M1/M2 ratio. Here, CCL11 is linked to mouth disorder.